4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide Product Information
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide is listed under Intermediate and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Atorvastatin. The product is supplied by Clearsynth under CAT No. CS-T-24126.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide
CAS No.
125971-96-2
CAT No.
CS-T-24126
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C₂₆H₂₄FNO₃
Molecular Weight
417.5
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide is supplied with detailed characterization data compliant with regulatory guideline. 4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Atorvastatin.
Overview
"An Atorvastatin intermediate. Atorvastatin is a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia."
Synonyms
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,-β-diphenyl-benzenebutanamide
Application Notes
"An Atorvastatin intermediate. Atorvastatin is a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.